Ethyl Pyruvate Promotes Proliferation of Regulatory T Cells by Increasing Glycolysis

Area of Science:

• Immunology
• Metabolic pathways
• T cell biology

Background:

• Ethyl pyruvate (EP) demonstrates anti-oxidant and anti-inflammatory effects.
• EP has previously shown potential in preventing type 1 diabetes by modulating regulatory T cells (Tregs).

Purpose of the Study:

• To investigate the mechanisms by which EP influences Treg proliferation and function.
• To determine the metabolic pathways involved in EP-driven Treg expansion.

Main Methods:

• In vitro differentiation of conventional T cells with EP treatment.
• Analysis of Treg proliferation, suppressive markers (perforin, IL-10), ATP levels, and glycolysis.
• Inhibition of oxidative phosphorylation and mTOR signaling pathway.
• In vivo administration of EP to mice and assessment of Treg populations.

Main Results:

• EP significantly increased Treg proliferation and suppressive function in vitro.
• EP-driven Treg expansion correlated with elevated ATP levels and increased glycolysis.
• EP did not require oxidative phosphorylation and did not inhibit the mTOR pathway.
• In vivo EP administration boosted Treg numbers in the peritoneal cavity and gut-associated lymphoid tissue.

Conclusions:

• Ethyl pyruvate promotes Treg proliferation and function primarily through enhanced glycolysis.
• EP administration, both in vitro and in vivo, leads to an increased number of Tregs.